or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    BNTC A Benitec Biopharma Limited -0.58
    ELMD B Electromed, Inc. -2.53
    SRPT B Sarepta Therapeutics, Inc. 1.08
    DYN C Dyne Therapeutics, Inc. 4.37
    SMMT C Summit Therapeutics plc 8.73
    PTCT D PTC Therapeutics, Inc. 12.08
    SLDB D Solid Biosciences Inc. 5.15
    FULC D Fulcrum Therapeutics, Inc. 0.14
    IONS D Ionis Pharmaceuticals, Inc. -0.57
    TRDA F Entrada Therapeutics, Inc. 0.73
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Muscular Dystrophy Biopharmaceutical Disease Duchenne Duchenne Muscular Dystrophy Biotechnology Medicine Biology Myotonic Dystrophy Antisense RNA Cancer Cystic Fibrosis Disorders Drug Discovery Dystrophin Facioscapulohumeral Muscular Dystrophy Gene Expression Genetic Genealogy Genetics Hepatitis B

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 11.29
    PINK C Simplify Health Care ETF 10.07
    BBP D BioShares Biotechnology Products Fund 6.22
    PBE D PowerShares Dynamic Biotech & Genome 5.48
    BTEC C Principal Healthcare Innovators Index ETF 5.39
    View all Dystrophy ETFs...
    Compare ETFs
    Compare BBP to PBE Compare IBRN to PBE Compare IBRN to PINK

        Dystrophy Stocks Recent News

        Date Stock Title
        Apr 26 PTCT Sector Update: Health Care Stocks Edge Higher Late Afternoon
        Apr 26 PTCT Q1 2024 PTC Therapeutics Inc Earnings Call
        Apr 26 PTCT PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
        Apr 26 PTCT PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
        Apr 26 PTCT Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
        Apr 25 PTCT PTC Therapeutics Q1 2024 Earnings: A Detailed Financial Review
        Apr 25 PTCT PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M
        Apr 25 PTCT PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
        Apr 25 SRPT Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
        Apr 25 SRPT Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
        Apr 25 IONS Ionis Publishes 2023 Corporate Responsibility Report
        Apr 24 PTCT PTC Therapeutics Q1 2024 Earnings Preview
        Apr 24 SMMT Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
        Apr 24 SRPT Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
        Apr 23 IONS Ionis to hold first quarter 2024 financial results webcast
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Muscular Dystrophy Biopharmaceutical Disease Duchenne Duchenne Muscular Dystrophy Biotechnology Medicine Biology Myotonic Dystrophy Antisense RNA Cancer Cystic Fibrosis Disorders Drug Discovery Dystrophin Facioscapulohumeral Muscular Dystrophy Gene Expression Genetic Genealogy Genetics Hepatitis B
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags